{"id":15796,"date":"2021-04-13T08:34:09","date_gmt":"2021-04-13T08:34:09","guid":{"rendered":"https:\/\/www.neuraxpharm.com\/it2\/?page_id=15796"},"modified":"2023-03-27T09:29:15","modified_gmt":"2023-03-27T09:29:15","slug":"lluis-perez","status":"publish","type":"page","link":"https:\/\/www.neuraxpharm.com\/ch-de\/ueber-uns\/geschaeftsfuehrung\/lluis-perez","title":{"rendered":"LLU\u00cdS P\u00c9REZ"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
\n\t\t\t<\/i>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

https:\/\/www.linkedin.com\/in\/lluis-perez-796bb934\/<\/a><\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t
\n\t\t
Neuraxpharm<\/a><\/div>\n\t\t<\/div>\n\t\t<\/div>\n\t\t<\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

LLU\u00cdS P\u00c9REZ<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Llu\u00eds P\u00e9rez kam im April 2018 als Chief Financial Officer (CFO) zu Neuraxpharm. Sein beruflicher Hintergrund und seine Expertise liegen in den Bereichen Finanzen und Corporate Finance Control, hinzu kommt umfangreiche internationale Erfahrung in gro\u00dfen multinationalen Unternehmen.<\/p>

Mehr als acht Jahre lang entwickelte er seine berufliche Laufbahn als Group CFO in verschiedenen Gesch\u00e4ftsbereichen innerhalb der Celsa-Gruppe, dem zweitgr\u00f6\u00dften Stahlproduzenten Europas mit Standorten in Gro\u00dfbritannien, Skandinavien und Polen, sowie als Group CFO f\u00fcr die Private Equity-gef\u00fchrte Goldcar-Gruppe.<\/p>

Er ist Experte f\u00fcr die Integration von Tochtergesellschaften, die standort\u00fcbergreifende Koordination von Finanzabteilungen, die Refinanzierung, die Analyse der Machbarkeit von Neuinvestitionen und die Leitung von Fusions- und \u00dcbernahmeprozessen.<\/p>

Er hat einen Bachelor-Abschluss (BSc) in Betriebswirtschaft von der Universitat Aut\u00f2noma de Barcelona und einen E-MBA.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

https:\/\/www.linkedin.com\/in\/lluis-perez-796bb934\/ Neuraxpharm LLU\u00cdS P\u00c9REZ Llu\u00eds P\u00e9rez kam im April 2018 als Chief Financial Officer (CFO) zu Neuraxpharm. Sein beruflicher Hintergrund und seine Expertise liegen in den Bereichen Finanzen und Corporate Finance Control, hinzu kommt umfangreiche internationale Erfahrung in gro\u00dfen multinationalen Unternehmen. Mehr als acht Jahre lang entwickelte er seine berufliche Laufbahn als Group CFO in […]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":1998,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-15796","page","type-page","status-publish","hentry"],"yoast_head":"\nLLU\u00cdS P\u00c9REZ - Neuraxpharm Switzerland<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.neuraxpharm.com\/de\/ueber-uns\/geschaeftsfuehrung\/lluis-perez\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LLU\u00cdS P\u00c9REZ\" \/>\n<meta property=\"og:description\" content=\"https:\/\/www.linkedin.com\/in\/lluis-perez-796bb934\/ Neuraxpharm LLU\u00cdS P\u00c9REZ Llu\u00eds P\u00e9rez kam im April 2018 als Chief Financial Officer (CFO) zu Neuraxpharm. Sein beruflicher Hintergrund und seine Expertise liegen in den Bereichen Finanzen und Corporate Finance Control, hinzu kommt umfangreiche internationale Erfahrung in gro\u00dfen multinationalen Unternehmen. Mehr als acht Jahre lang entwickelte er seine berufliche Laufbahn als Group CFO in […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.neuraxpharm.com\/de\/ueber-uns\/geschaeftsfuehrung\/lluis-perez\" \/>\n<meta property=\"og:site_name\" content=\"Neuraxpharm Switzerland\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-27T09:29:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.neuraxpharm.com\/ch-de\/wp-content\/uploads\/sites\/14\/2023\/03\/lluis-perez.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-de\/ueber-uns\/geschaeftsfuehrung\/lluis-perez\",\"url\":\"https:\/\/www.neuraxpharm.com\/de\/ueber-uns\/geschaeftsfuehrung\/lluis-perez\",\"name\":\"LLU\u00cdS P\u00c9REZ - Neuraxpharm Switzerland\",\"isPartOf\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-de\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/de\/ueber-uns\/geschaeftsfuehrung\/lluis-perez#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/de\/ueber-uns\/geschaeftsfuehrung\/lluis-perez#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.neuraxpharm.com\/ch-de\/wp-content\/uploads\/sites\/14\/2023\/03\/lluis-perez.jpg\",\"datePublished\":\"2021-04-13T08:34:09+00:00\",\"dateModified\":\"2023-03-27T09:29:15+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/de\/ueber-uns\/geschaeftsfuehrung\/lluis-perez#breadcrumb\"},\"inLanguage\":\"de-CH\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.neuraxpharm.com\/de\/ueber-uns\/geschaeftsfuehrung\/lluis-perez\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de-CH\",\"@id\":\"https:\/\/www.neuraxpharm.com\/de\/ueber-uns\/geschaeftsfuehrung\/lluis-perez#primaryimage\",\"url\":\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/14\/2023\/03\/27092606\/lluis-perez.jpg\",\"contentUrl\":\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/14\/2023\/03\/27092606\/lluis-perez.jpg\",\"width\":716,\"height\":700},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.neuraxpharm.com\/de\/ueber-uns\/geschaeftsfuehrung\/lluis-perez#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u00dcber uns\",\"item\":\"https:\/\/www.neuraxpharm.com\/ch-de\/ueber-uns\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gesch\u00e4ftsf\u00fchrung\",\"item\":\"https:\/\/www.neuraxpharm.com\/ch-de\/ueber-uns\/geschaeftsfuehrung\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"LLU\u00cdS P\u00c9REZ\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.neuraxpharm.com\/ch-de\/#website\",\"url\":\"https:\/\/www.neuraxpharm.com\/ch-de\/\",\"name\":\"Neuraxpharm Switzerland\",\"description\":\"Ein europ\u00e4ischer Marktf\u00fchrer f\u00fcr CNS-Produkte\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.neuraxpharm.com\/ch-de\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de-CH\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"LLU\u00cdS P\u00c9REZ - Neuraxpharm Switzerland","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.neuraxpharm.com\/de\/ueber-uns\/geschaeftsfuehrung\/lluis-perez","og_locale":"de_DE","og_type":"article","og_title":"LLU\u00cdS P\u00c9REZ","og_description":"https:\/\/www.linkedin.com\/in\/lluis-perez-796bb934\/ Neuraxpharm LLU\u00cdS P\u00c9REZ Llu\u00eds P\u00e9rez kam im April 2018 als Chief Financial Officer (CFO) zu Neuraxpharm. Sein beruflicher Hintergrund und seine Expertise liegen in den Bereichen Finanzen und Corporate Finance Control, hinzu kommt umfangreiche internationale Erfahrung in gro\u00dfen multinationalen Unternehmen. Mehr als acht Jahre lang entwickelte er seine berufliche Laufbahn als Group CFO in […]","og_url":"https:\/\/www.neuraxpharm.com\/de\/ueber-uns\/geschaeftsfuehrung\/lluis-perez","og_site_name":"Neuraxpharm Switzerland","article_modified_time":"2023-03-27T09:29:15+00:00","og_image":[{"url":"https:\/\/www.neuraxpharm.com\/ch-de\/wp-content\/uploads\/sites\/14\/2023\/03\/lluis-perez.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.neuraxpharm.com\/ch-de\/ueber-uns\/geschaeftsfuehrung\/lluis-perez","url":"https:\/\/www.neuraxpharm.com\/de\/ueber-uns\/geschaeftsfuehrung\/lluis-perez","name":"LLU\u00cdS P\u00c9REZ - Neuraxpharm Switzerland","isPartOf":{"@id":"https:\/\/www.neuraxpharm.com\/ch-de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.neuraxpharm.com\/de\/ueber-uns\/geschaeftsfuehrung\/lluis-perez#primaryimage"},"image":{"@id":"https:\/\/www.neuraxpharm.com\/de\/ueber-uns\/geschaeftsfuehrung\/lluis-perez#primaryimage"},"thumbnailUrl":"https:\/\/www.neuraxpharm.com\/ch-de\/wp-content\/uploads\/sites\/14\/2023\/03\/lluis-perez.jpg","datePublished":"2021-04-13T08:34:09+00:00","dateModified":"2023-03-27T09:29:15+00:00","breadcrumb":{"@id":"https:\/\/www.neuraxpharm.com\/de\/ueber-uns\/geschaeftsfuehrung\/lluis-perez#breadcrumb"},"inLanguage":"de-CH","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.neuraxpharm.com\/de\/ueber-uns\/geschaeftsfuehrung\/lluis-perez"]}]},{"@type":"ImageObject","inLanguage":"de-CH","@id":"https:\/\/www.neuraxpharm.com\/de\/ueber-uns\/geschaeftsfuehrung\/lluis-perez#primaryimage","url":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/14\/2023\/03\/27092606\/lluis-perez.jpg","contentUrl":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/14\/2023\/03\/27092606\/lluis-perez.jpg","width":716,"height":700},{"@type":"BreadcrumbList","@id":"https:\/\/www.neuraxpharm.com\/de\/ueber-uns\/geschaeftsfuehrung\/lluis-perez#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u00dcber uns","item":"https:\/\/www.neuraxpharm.com\/ch-de\/ueber-uns"},{"@type":"ListItem","position":2,"name":"Gesch\u00e4ftsf\u00fchrung","item":"https:\/\/www.neuraxpharm.com\/ch-de\/ueber-uns\/geschaeftsfuehrung"},{"@type":"ListItem","position":3,"name":"LLU\u00cdS P\u00c9REZ"}]},{"@type":"WebSite","@id":"https:\/\/www.neuraxpharm.com\/ch-de\/#website","url":"https:\/\/www.neuraxpharm.com\/ch-de\/","name":"Neuraxpharm Switzerland","description":"Ein europ\u00e4ischer Marktf\u00fchrer f\u00fcr CNS-Produkte","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.neuraxpharm.com\/ch-de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de-CH"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.neuraxpharm.com\/ch-de\/wp-json\/wp\/v2\/pages\/15796","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.neuraxpharm.com\/ch-de\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.neuraxpharm.com\/ch-de\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/ch-de\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/ch-de\/wp-json\/wp\/v2\/comments?post=15796"}],"version-history":[{"count":33,"href":"https:\/\/www.neuraxpharm.com\/ch-de\/wp-json\/wp\/v2\/pages\/15796\/revisions"}],"predecessor-version":[{"id":24845,"href":"https:\/\/www.neuraxpharm.com\/ch-de\/wp-json\/wp\/v2\/pages\/15796\/revisions\/24845"}],"up":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/ch-de\/wp-json\/wp\/v2\/pages\/1998"}],"wp:attachment":[{"href":"https:\/\/www.neuraxpharm.com\/ch-de\/wp-json\/wp\/v2\/media?parent=15796"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}